NMTR

Q: What is the price of 9 Meters Biopharma (NMTR) today?

The price of 9 Meters Biopharma (NMTR) today is $ 0.00, with return of 0% compared to the last year. The price of 9 Meters Biopharma (NMTR) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of 9 Meters Biopharma (NMTR) and international markets.

Q: When does 9 Meters Biopharma (NMTR) pay dividends?

9 Meters Biopharma (NMTR) did not distribute dividends in the last year.

Q: Is 9 Meters Biopharma (NMTR) worth it?

Currently, 9 Meters Biopharma (NMTR) is priced at $ 0.00, with a P/E of 0.06%, representing a deviation of -477% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of -357.02%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy 9 Meters Biopharma (NMTR) stock?

Investing in stocks of 9 Meters Biopharma (NMTR) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of 9 Meters Biopharma (NMTR) yield today?

The yield of 9 Meters Biopharma (NMTR) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of -357.02%.If you wanted to buy 100 stocks of 9 Meters Biopharma (NMTR) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

9 Meters Biopharma Inc.

This asset is no longer available for investment.

View all assets

Price

$ -

return (12m)

0.00%

p/e

0.06

p/bv

0.60

DIVIDEND YIELD

-357.02%

price NMTR

NMTR

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of NMTR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals NMTR

review the fundamentals of 9 Meters Biopharma shares

P/E

0.06

Sector: -3.66 Industry: -3.66

P/SALES RATIO (PSR)

Sector: -3.63 Industry: -3.63

P/BV

0.60

Sector: 2.08 Industry: 2.08

DIVIDEND YIELD (DY)

-357.02%

Sector: - Industry: -

ROA

-738.37%

Sector: -63.97% Industry: -63.97%

ROE

1,091.65%

Sector: -66.68% Industry: -66.68%

ROIC

Sector: -1,128.96% Industry: -1,128.96%

NET MARGIN

0.00%

Sector: -41.05% Industry: -41.05%

GROSS MARGIN

0.00%

Sector: 39.22% Industry: 39.22%

OPERATING MARGIN

0.00%

Sector: -40.98% Industry: -40.98%

P/EBITDA

0.06

Sector: -3.63 Industry: -3.63

P/EBIT

0.06

Sector: -3.76 Industry: -3.76

P/ASSET

-0.41

Sector: 1.47 Industry: 1.47

BVPS

-0.46

Sector: 1.77 Industry: 1.77

EPS

-5.06

Sector: -2.03 Industry: -2.03

EQUITY RATIO

-0.68

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

13.33%

Sector: - Industry: -

Fundamentals NMTR

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.59	6.21	31.69%	2.51%	$ 492.17 B	27.26%
PFE	14.74	1.56	10.56%	6.75%	$ 144.85 B	15.65%
ABBV	169.26	-155.52	-91.88%	2.87%	$ 404.20 B	4.00%
NVO	16.95	9.78	57.70%	2.87%	$ 261.35 B	32.78%
MRK	14.51	0.00	0.00%	2.97%	$ 276.10 B	29.63%
AZN	31.24	6.39	20.45%	1.65%	$ 293.60 B	16.17%
BMY	18.61	6.04	32.47%	4.49%	$ 112.40 B	12.57%
GILD	18.56	7.02	37.80%	2.61%	$ 150.53 B	27.88%
ZTS	21.25	10.44	49.11%	1.57%	$ 56.34 B	28.21%
REGN	18.10	2.68	14.79%	0.44%	$ 82.84 B	32.13%
HALO	14.24	16.83	118.17%	0.00%	$ 8.48 B	47.91%
AMGN	25.05	18.24	72.82%	2.92%	$ 175.44 B	19.47%
MCK	25.09	-175.07	-697.75%	0.38%	$ 101.19 B	1.04%
VRTX	32.31	6.86	21.22%	0.00%	$ 118.75 B	31.35%
CAH	30.01	-17.53	-58.40%	1.01%	$ 47.86 B	0.68%
ADMA	20.48	9.95	48.57%	0.00%	$ 4.29 B	42.87%
BIIB	17.15	1.51	8.83%	0.00%	$ 27.58 B	15.98%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

NMTR Historical Dividends

current DY: -357.02%

5-year average DY: -213.86%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	06/28/2024	07/29/2024	0,20000000
Dividend	03/25/2024	04/25/2024	0,20000000
Dividend	12/26/2023	01/26/2024	0,20000000
Dividend	09/21/2023	10/26/2023	0,30000000
Dividend	06/16/2023	07/26/2023	0,30000000
Dividend	03/20/2023	04/26/2023	0,40000000
Dividend	12/27/2022	01/26/2023	0,25440000
Dividend	09/26/2022	10/26/2022	0,01280000
Dividend	06/27/2022	07/25/2022	0,25600000
Dividend	03/24/2022	04/25/2022	0,25600000
Dividend	12/27/2021	01/25/2022	0,27200000
Dividend	09/23/2021	10/25/2021	0,27200000
Dividend	06/24/2021	07/26/2021	0,27200000
Dividend	03/25/2021	04/26/2021	0,27200000
Dividend	12/17/2020	01/25/2021	0,08000000
Dividend	09/24/2020	10/26/2020	0,06400000
Dividend	07/01/2020	07/27/2020	0,04000000
Dividend	12/20/2019	01/27/2020	0,80000000
Dividend	09/19/2019	10/25/2019	0,80000000
Dividend	06/24/2019	07/25/2019	0,80000000
Dividend	03/29/2019	04/25/2019	0,80000000
Dividend	12/14/2018	01/25/2019	0,80000000
Dividend	09/27/2018	10/26/2018	0,80000000
Dividend	06/28/2018	07/26/2018	0,80000000
Dividend	03/29/2018	04/26/2018	0,80000000
Dividend	12/18/2017	01/25/2018	0,80000000
Dividend	09/25/2017	10/25/2017	0,80000000
Dividend	06/26/2017	07/25/2017	0,80000000
Dividend	03/27/2017	04/25/2017	0,80000000
Dividend	12/27/2016	01/26/2017	0,96000000
Dividend	09/26/2016	10/28/2016	0,96000000

ABOUT THE COMPANY 9 Meters Biopharma

9 Meters Biopharma Inc.

Average user rating I10

4.0 (1 people)

United States

16 years

Founded: 2010

2016

Time since IPO - 10 years

12

Employees

The Company 9 Meters Biopharma Inc. (United States), is listed on Nasdaq with a market value of $ -3.81 Millions, having an equity of $ -6.30 Millions.

With a total of 12 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -68.76 Millions.

As for its main indicators, the Company has a P/E ratio of 0.06, a P/BV ratio of 0.60 and in the last 12 months the dividend yield of NMTR was at -357.02%.

The Company is traded internationally through the ticker NMTR.

Market cap

$ -3.81 Millions

Net worth

$ -6.30 Millions

US$ -6,299,205.00

Assets

$ 9.31 Millions

US$ 9,313,037.00

Total Shares Outstanding

13.59 Millions

13,591,000

Average Daily Trading Volume

$ 66.60 Thousand

US$ 66,598.00

Sector

Health Care

Industry

Biotechnology

NMTR

NMTR revenue and profits

Financial Results NMTR

DRAG THE FRAME TO SEE MORE DATA

NMTR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 834.16 43,58% (12M)

P/E

25.09

0.38%

ROE

-697.75%

P/BV

-175.07

CAH - Cardinal Health

$ 213.56 73,39% (12M)

P/E

30.01

1.01%

ROE

-58.40%

P/BV

-17.53

JNJ - Johnson & Johnson

$ 218.55 56,36% (12M)

P/E

19.59

2.51%

ROE

31.69%

P/BV

6.21

MRK - Merck & Co.

$ 111.01 15,08% (12M)

P/E

14.51

2.97%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.58 5,33% (12M)

P/E

14.74

6.75%

ROE

10.56%

P/BV

1.56

ABBV - AbbVie

$ 221.89 35,05% (12M)

P/E

169.26

2.87%

ROE

-91.88%

P/BV

-155.52

AZN - AstraZeneca

$ 96.34 49,81% (12M)

P/E

31.24

1.65%

ROE

20.45%

P/BV

6.39

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 834.16 43,58% (12 M)

P/L

25.09

0.38%

ROE

-697.75%

P/VP

-175.07

CAH - Cardinal Health

$ 213.56 73,39% (12 M)

P/L

30.01

1.01%

ROE

-58.40%

P/VP

-17.53

JNJ - Johnson & Johnson

$ 218.55 56,36% (12 M)

P/L

19.59

2.51%

ROE

31.69%

P/VP

6.21

MRK - Merck & Co.

$ 111.01 15,08% (12 M)

P/L

14.51

2.97%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.58 5,33% (12 M)

P/L

14.74

6.75%

ROE

10.56%

P/VP

1.56

ABBV - AbbVie

$ 221.89 35,05% (12 M)

P/L

169.26

2.87%

ROE

-91.88%

P/VP

-155.52

AZN - AstraZeneca

$ 96.34 49,81% (12 M)

P/L

31.24

1.65%

ROE

20.45%

P/VP

6.39

Frequently Asked Questions

What is the price of 9 Meters Biopharma (NMTR) today?

The price of 9 Meters Biopharma (NMTR) today is $ 0.00, with return of 0% compared to the last year. The price of 9 Meters Biopharma (NMTR) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of 9 Meters Biopharma (NMTR) and international markets.

When does 9 Meters Biopharma (NMTR) pay dividends?

9 Meters Biopharma (NMTR) did not distribute dividends in the last year.

Is 9 Meters Biopharma (NMTR) worth it?

Currently, 9 Meters Biopharma (NMTR) is priced at $ 0.00, with a P/E of 0.06%, representing a deviation of -477% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of -357.02%. The total shareholder return was 0.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy 9 Meters Biopharma (NMTR) stock?

Investing in stocks of 9 Meters Biopharma (NMTR) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of 9 Meters Biopharma (NMTR) yield today?

The yield of 9 Meters Biopharma (NMTR) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of -357.02%.

If you wanted to buy 100 stocks of 9 Meters Biopharma (NMTR) today, the total investment would be $ 0.00, based on the current price of $ 0.00.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 0.00
In 5 years: $ 0.00
In 10 years: $ 0.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NMTR

9 Meters Biopharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of NMTR

review the fundamentals of 9 Meters Biopharma shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: -357.02%

5-year average DY: -213.86%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY 9 Meters Biopharma

9 Meters Biopharma Inc.

United States

16 years

2016

12

PROFIT X PRICE NMTR

Financial Results NMTR

NMTR cash flow

asset growth - NMTR

NMTR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions